Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq set for lower open as AI stocks slide on debt concerns
- U.S. producer prices rise by 1.3% month-on-month in September
- Oil prices slips as US weighs easing sanctions on 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Walmart stock: Deutsche Bank gets bullish amid pricing tailwinds
| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 36.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.89 | 52 Week High | $19.98 | |||
| Open | $36.89 | 52 Week Low | $10.52 | |||
| Day High | $36.89 | P/E | N/A | |||
| Day Low | $36.89 | EPS | $-1.45 | |||
| Volume | 6,256 | |||||
